Subcutaneous live flu injection protected mice at 277 days without detectable lung virus

A single subcutaneous injection of a live, unattenuated influenza virus protected mice against a lethal challenge, with 100% survival observed at 277 days after immunization. The animal study, published in Virologica Sinica, found no detectable infectious virus in the lungs or other organs, while the injected virus remained restricted to the injection site and draining lymph nodes.

Researchers immunized mice with a high dose of replication-competent A/Puerto Rico/8/34 (H1N1) influenza virus administered under the skin. The investigators compared this approach with intramuscular delivery and with inactivated or recombinant hemagglutinin vaccines. According to the study report, the subcutaneous treatment elicited strong neutralizing antibodies and fully protected the mice against lethal challenge. Survival at 277 days post-immunization was 100% and was reported to outperform the other immunization approaches tested.

Single-cell transcriptomic analysis indicated that subcutaneous delivery produced a localized type I interferon response that subsequently transitioned into a robust germinal center response, with extensive plasma cell differentiation and memory B cell formation. The report said this pattern provided a mechanistic explanation for the strong immune response, although the experiments were conducted in mice. Intramuscular immunization, by comparison, induced weaker and slower cellular responses. No direct evidence in the supplied report established that any particular cell population caused the observed protection or remained responsible for it at 277 days.

The findings concern a single subcutaneous dose of replication-competent live virus and do not establish safety or efficacy in humans. The researchers cautioned that the mouse results require further toxicological assessment in larger animals, including tests involving high-pathogenicity strains such as H5N1, before clinical translation. Their proposed strategy is intended to examine whether live-virus immunization can retain strong immune responses while avoiding respiratory pathology, but that broader safety profile has not yet been demonstrated beyond the mouse experiments reported.

Subject of Research: Mouse study of subcutaneous immunization with live influenza virus

Article Title: Skin injection of live flu virus provides durable protection without lung damage

Article References: Skin injection of live flu virus provides durable protection without lung damage. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: influenza, live virus vaccine, subcutaneous injection, H1N1, mouse study, durable protection, neutralizing antibodies, respiratory pathology, single-cell transcriptomics, Skin, injection, live